KEMPER Corp KMPR Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000860748-25-000131
cik 860748
name KEMPER CORP
sic 6331
countryba US
stprba IL
cityba CHICAGO
zipba 60601
bas1 200 E. RANDOLPH ST.
bas2 SUITE 3300
baph 3126614600
countryma US
stprma IL
cityma CHICAGO
zipma 60601
mas1 200 E. RANDOLPH ST.
mas2 SUITE 3300
countryinc US
stprinc DE
ein 954255452
former UNITRIN INC
changed 19930328
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250507
accepted 2025-05-07 16:13:00.0
prevrpt 0
detail 1
instance kmpr-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000860748-25-000131 20241231 Accrued Liabilities And Other Liabilities 705200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Assets 6352900000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Assets 4850600000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 741500000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 4700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 1231400000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 741500000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 6600000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 407200000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 6558600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 6600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 9000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 1232000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 511900000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20241231 Borrowings Under Guaranteed Investment Agreements 541300000.0000 USD 0 us-gaap/2025 Federal Home Loan Bank Advances Branch Of F H L B Bank= Federal Home Loan Bank Of Chicago; Legal Entity= United Insurance Company Of America;
0000860748-25-000131 20250331 Borrowings Under Guaranteed Investment Agreements 632000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Capital Lease Obligations Incurred 5100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Cash 115400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Change In Discount Rate On Future Life Policyholder Benefits -18100000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20241231 Common Stock Shares Outstanding 63840442.0000 shares 0 us-gaap/2025
0000860748-25-000131 20250331 Comprehensive Income Net Of Tax 142900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 1600000.0000 USD 0 us-gaap/2025 Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 8800000.0000 USD 0 us-gaap/2025 Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20250331 Deferred Income Tax Liabilities Net 6600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Deferred Policy Acquisition Costs 595900000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Deferred Policy Acquisition Costs 143600000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 463100000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 470900000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Depreciation Amortization And Accretion Net 12500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Dividends 20200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Earnings Per Share Diluted 1.1000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Equity Securities Fv Ni 218500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 300000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 1700000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 13200000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 15800000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 10400000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20250331 Equity Securities Fv Ni Cost 211300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Increase Decrease In Deferred Policy Acquisition Costs 4200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Increase Decrease In Income Taxes 26900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Interest Paid Net 20000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Interest Paid Net 24500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Liability For Claims And Claims Adjustment Expense 2611900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie; Product Or Service= Property And Casualty Insurance Product Line;
0000860748-25-000131 20250331 Liability For Future Policy Benefits Period Expense 200000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1;
0000860748-25-000131 20241231 Life Insurance Corporate Or Bank Owned Amount 539200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Life Insurance Corporate Or Bank Owned Amount 546500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Loans Insurance Policy 279800000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Long Term Debt Current 0.0000 USD 0 us-gaap/2025 Debt Instrument= Senior Notes4.35 Percent Due February152025; Longterm Debt Type= Senior Notes;
0000860748-25-000131 20241231 Minority Interest -4100000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Net Investment Income 101200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Noncontrolling Interest Other Changes 200000.0000 USD 1 0000860748-25-000131 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20250331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax 1300000.0000 USD 1 us-gaap/2025 Credit Loss Status= Credit Losses;
0000860748-25-000131 20250331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax 2100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Comprehensive Income Loss Net Of Tax 43200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Receivables 100000.0000 USD 0 us-gaap/2025 Financial Instrument= Equity Securities;
0000860748-25-000131 20240331 Payments To Acquire Available For Sale Securities Debt 286900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 80600000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments; Product Or Service= Life;
0000860748-25-000131 20250331 Premiums Earned Net 99700000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Receivable Allowance For Doubtful Accounts 6400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 11900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Proceeds From Sale Of Equity Securities Fv Ni 13400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Profit Loss -2700000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20250331 Profit Loss 99700000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20240331 Repayments Of Senior Debt 0.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Revenues 141900000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Revenues 882500000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Stockholders Equity -687800000.0000 USD 0 us-gaap/2025 Equity Components= Aoci Gain Loss Debt Securities Available For Sale With Allowance For Credit Loss Parent;
0000860748-25-000131 20250331 Stockholders Equity 0.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000860748-25-000131 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1845300000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -1100000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20240331 Stock Issued During Period Shares Employee Stock Ownership Plan 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 800000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20241231 Unearned Premiums 11200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Accrued Liabilities And Other Liabilities 715500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Additional Paid In Capital Common Stock 1863600000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Assets 374100000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 86800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 86800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 205200000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 4300000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Benefits Losses And Expenses 1073200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Borrowings Under Guaranteed Investment Agreements 637700000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Borrowings Under Guaranteed Investment Agreements 536200000.0000 USD 0 us-gaap/2025 Federal Home Loan Bank Advances Branch Of F H L B Bank= Federal Home Loan Bank Of Chicago; Investment Type= Federal Home Loan Bank Certificates And Obligations F H L B; Legal Entity= United Insurance Company Of America;
0000860748-25-000131 20240331 Change In Discount Rate On Future Life Policyholder Benefits 141100000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20250331 Common Stock Shares Outstanding 63978865.0000 shares 0 us-gaap/2025
0000860748-25-000131 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 140200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 300000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 9300000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Deferred Income Tax Liabilities Net 14800000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20231231 Deferred Policy Acquisition Costs 427000000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20231231 Deferred Policy Acquisition Costs 22000000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 4100000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000860748-25-000131 20240331 Dividends 19500000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20250331 Earnings Per Share Basic 1.5600 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Equity Method Investments 185100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Equity Securities Fv Ni 1100000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 3800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20241231 Equity Securities Fv Ni 183600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20241231 Equity Securities Fv Ni 183600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 10200000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20250331 Equity Securities Fv Ni 4800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20250331 Gain Loss On Asset Impairment Charges 300000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20250331 Gain Loss On Asset Impairment Charges -300000.0000 USD 1 0000860748-25-000131 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20240331 Income Tax Expense Benefit 16400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Income Tax Receivable 40900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve 43100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Increase Decrease In Reinsurance Recoverable 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Interest And Other Expenses 14000000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20250331 Interest And Other Expenses 11400000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20241231 Investments 8888500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Investments 8592100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Liability For Claims And Claims Adjustment Expense 5811600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Liability For Claims And Claims Adjustment Expense 5867100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Liability For Claims And Claims Adjustment Expense 2637600000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000860748-25-000131 20250331 Life Insurance Corporate Or Bank Owned Amount 546500000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Loans Insurance Policy 280700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Long Term Debt Current 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Long Term Debt Noncurrent 941700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Long Term Debt Noncurrent 942100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Net Cash Provided By Used In Financing Activities -19700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Net Cash Provided By Used In Investing Activities 351100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Net Income Loss Attributable To Noncontrolling Interest -1100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Net Investment Income 41100000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Net Investment Income 50500000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Other Comprehensive Income Loss Before Tax 54000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Other Comprehensive Income Loss Tax 6700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Other Income 2200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Other Receivables 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Other Receivables 100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Other Short Term Investments 545300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Payments To Acquire Equity Securities Fv Ni 20500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments To Acquire Interest In Subsidiaries And Affiliates 15000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 164700000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments; Product Or Service= Commercial Automobile;
0000860748-25-000131 20240331 Premiums Earned Net 675300000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments; Product Or Service= Specialty Automobile;
0000860748-25-000131 20250331 Premiums Earned Net 10500000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments; Product Or Service= Property;
0000860748-25-000131 20250331 Premiums Earned Net 962200000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Earned Net 208500000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments; Product Or Service= Commercial Automobile;
0000860748-25-000131 20250331 Premiums Earned Net 753700000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments; Product Or Service= Specialty Automobile;
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 0.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Receivable At Carrying Value 49800000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20241231 Premiums Receivable At Carrying Value 8200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 1056400000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Proceeds From Repayments Of Secured Debt 20000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Proceeds From Sale And Maturity Of Available For Sale Securities 323200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Profit Loss -1100000.0000 USD 1 us-gaap/2025 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20240331 Profit Loss 71300000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20240331 Revenues 1024400000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Revenues 1162800000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20231231 Stockholders Equity -360800000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20240331 Stockholders Equity -617200000.0000 USD 0 us-gaap/2025 Equity Components= Aoci Gain Loss Debt Securities Available For Sale With Allowance For Credit Loss Parent;
0000860748-25-000131 20241231 Stockholders Equity -3200000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000860748-25-000131 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2505000000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -360800000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -200000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20250331 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025
0000860748-25-000131 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -1100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Accrued Liabilities And Other Liabilities 1700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20241231 Assets 12630400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Assets 11377900000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Available For Sale Debt Securities Amortized Cost Basis 13700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 6600000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 1800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 413000000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 4700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 371800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 371300000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 22500000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 394300000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20240331 Benefits Losses And Expenses -130000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Benefits Losses And Expenses -916100000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Capital Lease Obligations Incurred 5700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 64100000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 115400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240630 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 62600000.0000 USD 2 us-gaap/2025
0000860748-25-000131 20240331 Debt And Equity Securities Realized Gain Loss 6600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 9300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20250331 Deferred Income Tax Assets Net 73400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 628900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Earnings Per Share Diluted 1.5400 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 9500000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Equity Securities Fv Ni 183600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20250331 Equity Securities Fv Ni 10200000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20250331 Equity Securities Fv Ni Gain Loss 100000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20240331 Income Loss From Equity Method Investments 400000.0000 USD 1 us-gaap/2025 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0000860748-25-000131 20250331 Income Loss From Equity Method Investments -600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Income Loss From Equity Method Investments 500000.0000 USD 1 us-gaap/2025 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0000860748-25-000131 20241231 Liabilities 9846100000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Liability For Claims And Claims Adjustment Expense 9400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Liability For Future Policy Benefits Period Expense 200000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1;
0000860748-25-000131 20241231 Loans Insurance Policy 280700000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Net Income Loss 99700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Noncontrolling Interest Other Changes 700000.0000 USD 1 0000860748-25-000131 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20240331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax 1300000.0000 USD 1 us-gaap/2025 Credit Loss Status= Credit Losses;
0000860748-25-000131 20250331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax 69200000.0000 USD 1 us-gaap/2025 Credit Loss Status= No Credit Losses;
0000860748-25-000131 20240331 Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Other Income 300000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Other Short Term Investments 28000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Payments For Proceeds From Short Term Investments -493600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments For Repurchase Of Common Stock 4000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Payments To Acquire Mortgage Notes Receivable 27400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 840000000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Earned Net 200000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1;
0000860748-25-000131 20231231 Premiums Receivable Allowance For Doubtful Accounts 13900000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Premiums Receivable At Carrying Value 10500000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Receivable At Carrying Value 895500000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 8200000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20250331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 5900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Proceeds From Stock Plans 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Realized Investment Gains Losses 6600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Retained Earnings Accumulated Deficit 1231600000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Revenues 1014000000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Share Based Awards Net Of Shares Exchanged -6100000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20240331 Share Based Awards Net Of Shares Exchanged -6100000.0000 USD 1 0000860748-25-000131 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20250331 Share Based Awards Net Of Shares Exchanged -2500000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20250331 Share Based Awards Net Of Shares Exchanged -2500000.0000 USD 1 0000860748-25-000131 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20231231 Shares Issued 64100000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20250331 Stockholders Equity 2917600000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Stockholders Equity 8000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000860748-25-000131 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6400000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6400000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1308900000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20250331 Stock Repurchased And Retired During Period Shares 64000.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -304500000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Accrued Liabilities And Other Liabilities 500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -261300000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Assets 12630400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 3325400000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 1233200000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 486800000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 722300000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 67000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 3615500000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Borrowings Under Guaranteed Investment Agreements 637700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 50000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Common Stock Par Or Stated Value Per Share 0.1000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 96000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20250331 Deferred Income Tax Assets Net 2200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20231231 Deferred Policy Acquisition Costs 142700000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Deferred Policy Acquisition Costs 100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Deferred Policy Acquisition Costs 579700000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 630000000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 651200000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Dividends 19500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Equity Securities Fv Ni 13100000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20241231 Equity Securities Fv Ni 218500000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20250331 Equity Securities Fv Ni 7000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 1900000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 2600000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20250331 Equity Securities Fv Ni 232300000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20241231 Goodwill 1250700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Income Loss Including Portion Attributable To Noncontrolling Interest 86600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Income Taxes Paid Net 0.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Increase Decrease In Income Taxes 22700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Increase Decrease In Other Operating Capital Net -5200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Increase Decrease In Premiums Receivable -4400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Liabilities And Stockholders Equity 12467300000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Liability For Claims And Claims Adjustment Expense 3229500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie; Product Or Service= Life And Health Insurance Product Line;
0000860748-25-000131 20250331 Liability For Claims And Claims Adjustment Expense 2637600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie; Product Or Service= Property And Casualty Insurance Product Line;
0000860748-25-000131 20241231 Life Insurance Corporate Or Bank Owned Amount 539200000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Net Cash Provided By Used In Operating Activities 180000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Net Income Loss Attributable To Noncontrolling Interest -2700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Comprehensive Income Loss Tax 10800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Cost And Expense Operating 294500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Income 700000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Other Investments 217100000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Other Investments 244500000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Other Receivables 185700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Payments For Proceeds From Other Investing Activities -700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Receivable Allowance For Doubtful Accounts 5400000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 1064600000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 3500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Proceeds From Life Insurance Policies 4900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Proceeds From Sale And Collection Of Mortgage Notes Receivable 34100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Proceeds From Stock Plans 800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Revenues 106200000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20250331 Revenues 148800000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Share Based Awards Issued During Period Net Of Shares Exchanged 200000.0000 shares 1 0000860748-25-000131 Equity Components= Common Stock;
0000860748-25-000131 20231231 Stockholders Equity 160600000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Liability For Future Policy Benefit Adjustment Attributable To Parent;
0000860748-25-000131 20241231 Stockholders Equity 380300000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Liability For Future Policy Benefit Adjustment Attributable To Parent;
0000860748-25-000131 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -335000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6400000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1854900000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1863600000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20250331 Stock Repurchased And Retired During Period Value 4000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Stock Repurchased And Retired During Period Value 1800000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 12200000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 12200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 12200000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 12200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Assets 11084600000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Assets 6527300000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 6409600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 1700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 6117600000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 4200000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 104700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 3339700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 1230300000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20241231 Common Stock Shares Issued 63840442.0000 shares 0 us-gaap/2025
0000860748-25-000131 20250331 Common Stock Shares Issued 63978865.0000 shares 0 us-gaap/2025
0000860748-25-000131 20241231 Common Stock Value Outstanding 6400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 2000000.0000 USD 0 us-gaap/2025 Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20231231 Deferred Policy Acquisition Costs 600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20231231 Deferred Policy Acquisition Costs 569700000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Deferred Policy Acquisition Costs 436100000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 176900000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Equity Method Investments 186300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Equity Method Investments 17600000.0000 USD 0 us-gaap/2025 Investment Type= Alternative Energy Partnership Investments;
0000860748-25-000131 20250331 Equity Method Investments 17300000.0000 USD 0 us-gaap/2025 Investment Type= Alternative Energy Partnership Investments;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Equity Securities Fv Ni 11300000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20241231 Equity Securities Fv Ni 10900000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 500000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 7500000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 196900000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20240331 Income Taxes Paid Net 10400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Income Tax Expense Benefit 24200000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Income Tax Receivable 63400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Increase Decrease In Other Operating Capital Net -24900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20231231 Liability For Claims And Claims Adjustment Expense 2680500000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000860748-25-000131 20241231 Liability For Claims And Claims Adjustment Expense 2611900000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000860748-25-000131 20241231 Long Term Debt Current 449900000.0000 USD 0 us-gaap/2025 Debt Instrument= Senior Notes4.35 Percent Due February152025; Longterm Debt Type= Senior Notes;
0000860748-25-000131 20240331 Net Cash Provided By Used In Operating Activities 43000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Net Investment Income 48400000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Other Comprehensive Income Loss Net Of Tax 43200000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20250331 Other Income 1300000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Other Investments 244500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Other Receivables 300000.0000 USD 0 us-gaap/2025 Financial Instrument= Equity Securities;
0000860748-25-000131 20241231 Other Short Term Investments 1037100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Other Short Term Investments 31600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Payments For Proceeds From Other Investing Activities -300000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Payments For Repurchase Of Common Stock 0.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments Of Dividends 20200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 97300000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Earned Net 11100000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments; Product Or Service= Property;
0000860748-25-000131 20240331 Premiums Earned Net 94600000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20250331 Premiums Earned Net 1061900000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 2400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Proceeds From Life Insurance Policies 2900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Proceeds From Sale Of Equity Securities Fv Ni 7300000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 7600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Shares Issued 64400000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20231231 Stockholders Equity 2500000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000860748-25-000131 20240331 Stockholders Equity 2500000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000860748-25-000131 20240331 Stockholders Equity 272100000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Liability For Future Policy Benefit Adjustment Attributable To Parent;
0000860748-25-000131 20240331 Stockholders Equity -335000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20250331 Stockholders Equity -633100000.0000 USD 0 us-gaap/2025 Equity Components= Aoci Gain Loss Debt Securities Available For Sale With Allowance For Credit Loss Parent;
0000860748-25-000131 20250331 Unearned Premiums 1361600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Unearned Premiums 14500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20241231 Additional Paid In Capital Common Stock 1854900000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Assets 4731700000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Assets 715300000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20241231 Available For Sale Debt Securities Amortized Cost Basis 7295000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 408000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 5000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 3519600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 6558600000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 104700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20240331 Benefits Losses And Expenses -813300000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Borrowings Under Guaranteed Investment Agreements 541300000.0000 USD 0 us-gaap/2025 Federal Home Loan Bank Advances Branch Of F H L B Bank= Federal Home Loan Bank Of Chicago; Investment Type= Federal Home Loan Bank Certificates And Obligations F H L B; Legal Entity= United Insurance Company Of America;
0000860748-25-000131 20250331 Borrowings Under Guaranteed Investment Agreements 632000000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Borrowings Under Guaranteed Investment Agreements 536200000.0000 USD 0 us-gaap/2025 Federal Home Loan Bank Advances Branch Of F H L B Bank= Federal Home Loan Bank Of Chicago; Legal Entity= United Insurance Company Of America;
0000860748-25-000131 20241231 Cash 1000000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Cash 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 65400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Common Stock Dividends Per Share Cash Paid 0.3100 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Common Stock Par Or Stated Value Per Share 0.1000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Common Stock Value Outstanding 6400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 10700000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 200000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20241231 Deferred Income Tax Assets Net 1500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20231231 Deferred Policy Acquisition Costs 591700000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Deferred Policy Acquisition Costs 16200000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 162800000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 625900000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 649700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 3400000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000860748-25-000131 20240331 Depreciation Amortization And Accretion Net 14600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Dividends 20200000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20241231 Equity Securities Fv Ni 300000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 200000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20240331 Equity Securities Fv Ni Gain Loss 3400000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20250331 Equity Securities Fv Ni Gain Loss 100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Goodwill 1250700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Income Loss Including Portion Attributable To Noncontrolling Interest 119800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Income Tax Expense Benefit 100000.0000 USD 1 us-gaap/2025 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0000860748-25-000131 20250331 Increase Decrease In Deferred Policy Acquisition Costs 21200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve -69000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Liability For Claims And Claims Adjustment Expense 2597200000.0000 USD 0 us-gaap/2025 Product Or Service= Property Liability And Casualty Insurance Segment;
0000860748-25-000131 20250331 Noncontrolling Interest Other Changes 700000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20241231 Other Assets 436100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Other Assets 442200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax -109000000.0000 USD 1 us-gaap/2025 Credit Loss Status= No Credit Losses;
0000860748-25-000131 20240331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax 0.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax 500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Other Cost And Expense Operating 286400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Income 2600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Other Investments 217100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Other Receivables 189200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Payments To Acquire Interest In Subsidiaries And Affiliates 9600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Payments To Acquire Productive Assets 15300000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments To Acquire Productive Assets 7700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Premiums Earned Net 1087900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20231231 Premiums Receivable Allowance For Doubtful Accounts 1000000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20240331 Premiums Receivable Allowance For Doubtful Accounts 0.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 2600000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 2900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 2200000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Receivable At Carrying Value 955800000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Premiums Receivable At Carrying Value 977900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Proceeds From Payments For Other Financing Activities -1800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Profit Loss 97000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Realized Investment Gains Losses 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20231231 Stockholders Equity -2500000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000860748-25-000131 20240331 Stockholders Equity -1100000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000860748-25-000131 20241231 Stockholders Equity 8400000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000860748-25-000131 20250331 Stockholders Equity 366000000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Liability For Future Policy Benefit Adjustment Attributable To Parent;
0000860748-25-000131 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1852300000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0000860748-25-000131 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -4100000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -261300000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -6100000.0000 USD 0 us-gaap/2025 Equity Components= Noncontrolling Interest;
0000860748-25-000131 20250331 Stock Repurchased And Retired During Period Value 4000000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 2900000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Assets 41500000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidated Entities= Variable Interest Entity Primary Beneficiary; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Assets 774700000.0000 USD 0 us-gaap/2025 Consolidation Items= Corporate Non Segment;
0000860748-25-000131 20240331 Assets 771100000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20241231 Available For Sale Debt Securities Amortized Cost Basis 1700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 6409600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 6600000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Borrowings Under Guaranteed Investment Agreements 96400000.0000 USD 0 us-gaap/2025 Investment Type= Other Investments;
0000860748-25-000131 20250331 Borrowings Under Guaranteed Investment Agreements 95800000.0000 USD 0 us-gaap/2025 Investment Type= Other Investments;
0000860748-25-000131 20241231 Cash 64400000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 126700000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Common Stock Dividends Per Share Cash Paid 0.3200 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Comprehensive Income Net Of Tax 97100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -2700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 7100000.0000 USD 0 us-gaap/2025 Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20241231 Deferred Income Tax Assets Net 93300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Deferred Policy Acquisition Costs 1100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 1500000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Earnings Per Share Basic 1.1100 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Equity Securities Fv Ni 100000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 1000000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 19800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest;
0000860748-25-000131 20240331 Equity Securities Fv Ni Gain Loss 3400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Income Tax Expense Benefit 17300000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Income Tax Expense Benefit 22800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Income Tax Expense Benefit 100000.0000 USD 1 us-gaap/2025 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0000860748-25-000131 20240331 Increase Decrease In Reinsurance Recoverable -1800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Increase Decrease In Unearned Premiums 100800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Liability For Claims And Claims Adjustment Expense 3199700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie; Product Or Service= Life And Health Insurance Product Line;
0000860748-25-000131 20250331 Liability For Future Policy Benefits Period Expense 767300000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Loans Insurance Policy 279800000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Long Term Debt Current 449900000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Minority Interest -6100000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Net Cash Provided By Used In Financing Activities -481100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Net Cash Provided By Used In Investing Activities 39300000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Noncontrolling Interest Other Changes 200000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20250331 Other Assets 9800000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0000860748-25-000131 20240331 Other Comprehensive Income Loss Before Tax 32500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Other Receivables 3900000.0000 USD 0 us-gaap/2025 Financial Instrument= Debt Securities;
0000860748-25-000131 20240331 Payments For Proceeds From Short Term Investments -2400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Payments To Acquire Equity Securities Fv Ni 3100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments To Acquire Mortgage Notes Receivable 51700000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Payments To Acquire Real Estate Held For Investment 200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments To Acquire Real Estate Held For Investment 1100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 937300000.0000 USD 1 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Earned Net 83700000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments; Product Or Service= Life;
0000860748-25-000131 20250331 Premiums Earned Net 26000000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20231231 Premiums Receivable Allowance For Doubtful Accounts 0.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20231231 Premiums Receivable Allowance For Doubtful Accounts 12900000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Receivable Allowance For Doubtful Accounts 1000000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 300000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20241231 Premiums Receivable Allowance For Doubtful Accounts 2600000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 0.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 2200000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 200000.0000 USD 0 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20240331 Premiums Receivable At Carrying Value 2700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 1046100000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 1052700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Proceeds From Repayments Of Secured Debt 25500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Proceeds From Sale And Maturity Of Available For Sale Securities 215100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Profit Loss 70200000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Revenues 1143000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Revenues 1193000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Share Based Awards Issued During Period Net Of Shares Exchanged 300000.0000 shares 1 0000860748-25-000131 Equity Components= Common Stock;
0000860748-25-000131 20240331 Share Based Awards Net Of Shares Exchanged 0.0000 USD 1 0000860748-25-000131 Equity Components= Retained Earnings;
0000860748-25-000131 20241231 Shares Issued 63900000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20250331 Shares Issued 64000000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20231231 Stockholders Equity -530900000.0000 USD 0 us-gaap/2025 Equity Components= Aoci Gain Loss Debt Securities Available For Sale With Allowance For Credit Loss Parent;
0000860748-25-000131 20241231 Stockholders Equity -2200000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000860748-25-000131 20250331 Stockholders Equity -261300000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2911500000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Stock Repurchased And Retired During Period Shares 0.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20250331 Stock Repurchased And Retired During Period Value 2200000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20241231 Unearned Premiums 1264100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Assets 12467300000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Assets 61000000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidated Entities= Variable Interest Entity Primary Beneficiary; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Available For Sale Debt Securities Amortized Cost Basis 7372200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 400000000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 194200000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20241231 Available For Sale Securities Debt Securities 8900000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 13700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 6082600000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 275800000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Corporate Debt Securities;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 1700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 789300000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Loan Obligations;
0000860748-25-000131 20250331 Available For Sale Securities Debt Securities 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20240331 Benefits Losses And Expenses 1056400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Benefits Losses And Expenses -131600000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 62600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Common Stock Shares Authorized 100000000.0000 shares 0 us-gaap/2025
0000860748-25-000131 20250331 Debt And Equity Securities Realized Gain Loss 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 10700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20241231 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= U S Treasury And Government;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= Mandatorily Redeemable Preferred Stock;
0000860748-25-000131 20250331 Debt Securities Available For Sale Allowance For Credit Loss 0.0000 USD 0 us-gaap/2025 Financial Instrument= Other Mortgageand Assetbacked Securities;
0000860748-25-000131 20250331 Deferred Policy Acquisition Costs 647800000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Equity Securities Fv Ni 6700000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 2800000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 13100000.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20241231 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20241231 Equity Securities Fv Ni 10900000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds;
0000860748-25-000131 20250331 Equity Securities Fv Ni 232300000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= All Industries Otherthan Finance Insuranceand Real Estate; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Preferred Stock; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Equity Securities By Industry= Finance Insuranceand Real Estate; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Common Stock;
0000860748-25-000131 20250331 Equity Securities Fv Ni 20200000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities;
0000860748-25-000131 20250331 Equity Securities Fv Ni 196900000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Equity Securities; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 0.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Exchange Traded Funds; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20250331 Equity Securities Fv Ni 196900000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Partnership Interest; Valuation Technique= Fair Value Inputs Net Asset Value;
0000860748-25-000131 20241231 Equity Securities Fv Ni Cost 197100000.0000 USD 0 us-gaap/2025 Consolidated Entities= Consolidated Entity Excluding Vie;
0000860748-25-000131 20240331 Gain Loss On Asset Impairment Charges -1500000.0000 USD 1 0000860748-25-000131
0000860748-25-000131 20240331 Gain Loss On Asset Impairment Charges 1500000.0000 USD 1 0000860748-25-000131 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20240331 Income Loss From Equity Method Investments -6000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Income Tax Expense Benefit 2100000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Income Tax Expense Benefit 3000000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Increase Decrease In Premiums Receivable 78500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Increase Decrease In Unearned Premiums -24100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Liabilities 9555800000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Liabilities And Stockholders Equity 12630400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Liability For Claims And Claims Adjustment Expense 14700000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0000860748-25-000131 20240331 Liability For Future Policy Benefits Period Expense 756000000.0000 USD 1 us-gaap/2025 2 Includes a remeasurement loss related to the liability for future policyholder benefits within the Life insurance business of $0.2 million for the three months ended March 31, 2025 and 2024.
0000860748-25-000131 20240331 Net Income Loss 71300000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Net Investment Income 100400000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Net Investment Income 44300000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Other Assets 9200000.0000 USD 0 us-gaap/2025 Consolidated Entities= Variable Interest Entity Not Primary Beneficiary;
0000860748-25-000131 20240331 Other Comprehensive Income Loss Net Of Tax 25800000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Other Comprehensive Income Loss Net Of Tax 25800000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20240331 Other Income 1400000.0000 USD 1 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20241231 Other Receivables 1800000.0000 USD 0 us-gaap/2025 Financial Instrument= Debt Securities;
0000860748-25-000131 20240331 Payments Of Dividends 19500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Payments To Acquire Available For Sale Securities Debt 302500000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 1031900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Premiums Earned Net 5600000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments; Product Or Service= Accidentaland Health;
0000860748-25-000131 20250331 Premiums Earned Net 5500000.0000 USD 1 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments; Product Or Service= Accidentaland Health;
0000860748-25-000131 20231231 Premiums Receivable Allowance For Doubtful Accounts 12900000.0000 USD 0 us-gaap/2025 Business Segments= Specialty Property Casualty Insurance Segment; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Premiums Receivable Allowance For Doubtful Accounts 5400000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable Allowance For Doubtful Accounts 2400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Premiums Receivable At Carrying Value 906000000.0000 USD 0 us-gaap/2025 Consolidation Items= Operating Segments;
0000860748-25-000131 20250331 Premiums Receivable At Carrying Value 10300000.0000 USD 0 us-gaap/2025 Business Segments= Life Insurance Segment1; Consolidation Items= Operating Segments;
0000860748-25-000131 20240331 Proceeds From Payments For Other Financing Activities -6000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Proceeds From Sale And Collection Of Mortgage Notes Receivable 24100000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Repayments Of Secured Debt 20600000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Repayments Of Secured Debt 25900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Repayments Of Senior Debt 450000000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20250331 Retained Earnings Accumulated Deficit 1308900000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20250331 Revenues 27900000.0000 USD 1 us-gaap/2025 Consolidation Items= Material Reconciling Items;
0000860748-25-000131 20231231 Stockholders Equity 9500000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000860748-25-000131 20240331 Stockholders Equity 8700000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000860748-25-000131 20241231 Stockholders Equity 2788400000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Stockholders Equity -304500000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20250331 Stockholders Equity -2200000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Net Unrealized Investment Gain Loss;
0000860748-25-000131 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1014300000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2588700000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1066100000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2784300000.0000 USD 0 us-gaap/2025
0000860748-25-000131 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -304500000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0000860748-25-000131 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1231600000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0000860748-25-000131 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6400000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0000860748-25-000131 20240331 Stock Issued During Period Value Employee Stock Purchase Plan 900000.0000 USD 1 us-gaap/2025
0000860748-25-000131 20240331 Stock Issued During Period Value Employee Stock Purchase Plan 900000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Loans Insurance Policy us-gaap/2025 0 0 monetary I D Loans, Gross, Insurance Policy Amount before allowance of loans made to policy and contract holders using their life insurance contracts' cash value or separate accounts as collateral. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums over and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.
Deferred Income Tax Assets Net us-gaap/2025 0 0 monetary I D Deferred Income Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Payments Of Dividends us-gaap/2025 0 0 monetary D C Payments of Dividends Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
Payments To Acquire Real Estate Held For Investment us-gaap/2025 0 0 monetary D C Payment for Acquisition, Real Estate, Held-for-Investment The cash outflow associated with the purchase of real estate held for investment purposes.
Repayments Of Secured Debt us-gaap/2025 0 0 monetary D C Repayments of Secured Debt The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.
Realized Investment Gains Losses us-gaap/2025 0 0 monetary D C Realized Investment Gains (Losses) Amount of realized gain (loss) on investment.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Benefits Losses And Expenses us-gaap/2025 0 0 monetary D D Benefits, Losses and Expenses The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve us-gaap/2025 0 0 monetary D D Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Other Income us-gaap/2025 0 0 monetary D C Other Income Amount of revenue and income classified as other.
Payments To Acquire Interest In Subsidiaries And Affiliates us-gaap/2025 0 0 monetary D C Payments to Acquire Interest in Subsidiaries and Affiliates The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).
Profit Loss us-gaap/2025 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Debt And Equity Securities Realized Gain Loss us-gaap/2025 0 0 monetary D C Debt and Equity Securities, Realized Gain (Loss) Amount of realized gain (loss) on investment in debt and equity securities.
Increase Decrease In Income Taxes us-gaap/2025 0 0 monetary D D Increase (Decrease) in Income Taxes The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.
Equity Securities Fv Ni Gain Loss us-gaap/2025 0 0 monetary D C Equity Securities, FV-NI, Gain (Loss) Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Minority Interest us-gaap/2025 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Proceeds From Sale And Collection Of Mortgage Notes Receivable us-gaap/2025 0 0 monetary D D Proceeds from Sale and Collection of Mortgage Notes Receivable The cash inflow from proceeds from sale of receivables arising from the mortgage note on real estate; includes collections on mortgage notes receivable that are not classified as operating cash flows.
Interest And Other Expenses 0000860748-25-000131 1 0 monetary D D Interest and Other Expenses The Sum of (a) the cost of borrowed funds accounted for as interest that was charged against earnings during the period and (b) corporate general and administrative expenses charged against earnings during the period.
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.
Comprehensive Income Net Of Tax us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Available For Sale Securities Debt Securities us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Deferred Income Tax Liabilities Net us-gaap/2025 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Increase Decrease In Other Operating Capital Net us-gaap/2025 0 0 monetary D C Increase (Decrease) in Other Operating Assets and Liabilities, Net Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.
Long Term Debt Current us-gaap/2025 0 0 monetary I C Long-Term Debt, Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
Long Term Debt Noncurrent us-gaap/2025 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Other Cost And Expense Operating us-gaap/2025 0 0 monetary D D Other Cost and Expense, Operating The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
Other Investments us-gaap/2025 0 0 monetary I D Other Investments Amount of investments classified as other.
Payments For Repurchase Of Common Stock us-gaap/2025 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Other Comprehensive Income Loss Tax us-gaap/2025 0 0 monetary D D Other Comprehensive Income (Loss), Tax Amount of tax expense (benefit) allocated to other comprehensive income (loss).
Gain Loss On Asset Impairment Charges 0000860748-25-000131 1 0 monetary D C Gain (Loss) On Asset Impairment Charges Gain (Loss) On Asset Impairment Charges
Share Based Awards Issued During Period Net Of Shares Exchanged 0000860748-25-000131 1 0 shares D Share Based Awards Issued During Period Net Of Shares Exchanged The number of Shares issued during the period as a result of the exercise of stock options and vesting of restricted net of the shares withheld or surrendered to satisfy the exercise price and tax withholding obligations
Change In Discount Rate On Future Life Policyholder Benefits 0000860748-25-000131 1 0 monetary D C Change in Discount Rate on Future Life Policyholder Benefits Change in Discount Rate on Future Life Policyholder Benefits
Payments For Proceeds From Other Investing Activities us-gaap/2025 0 0 monetary D C Payment for (Proceeds from) Other Investing Activity Amount of cash (inflow) outflow from investing activity, classified as other.
Common Stock Value Outstanding us-gaap/2025 0 0 monetary I C Common Stock, Value, Outstanding Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares.
Debt Securities Available For Sale Allowance For Credit Loss us-gaap/2025 0 0 monetary I C Debt Securities, Available-for-Sale, Allowance for Credit Loss Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Income Loss Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Net Investment Income us-gaap/2025 0 0 monetary D C Net Investment Income Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.
Other Assets us-gaap/2025 0 0 monetary I D Other Assets Amount of assets classified as other.
Other Comprehensive Income Loss Before Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), before Tax Amount before tax, after reclassification adjustments of other comprehensive income (loss).
Payments To Acquire Available For Sale Securities Debt us-gaap/2025 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Premiums Earned Net us-gaap/2025 0 0 monetary D C Premiums Earned, Net Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
Premiums Receivable At Carrying Value us-gaap/2025 0 0 monetary I D Premiums Receivable, Net The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.
Proceeds From Stock Plans us-gaap/2025 0 0 monetary D D Proceeds from Stock Plans The cash inflow associated with the amount received from the stock plan during the period.
Stock Repurchased And Retired During Period Value us-gaap/2025 0 0 monetary D D Stock Repurchased and Retired During Period, Value Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Common Stock Dividends Per Share Cash Paid us-gaap/2025 0 0 perShare D Common Stock, Dividends, Per Share, Cash Paid Aggregate dividends paid during the period for each share of common stock outstanding.
Increase Decrease In Unearned Premiums us-gaap/2025 0 0 monetary D D Increase (Decrease) in Unearned Premiums Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income.
Other Receivables us-gaap/2025 0 0 monetary I D Other Receivables Amount due from parties in nontrade transactions, classified as other.
Payments To Acquire Equity Securities Fv Ni us-gaap/2025 0 0 monetary D C Payments to Acquire Equity Securities, FV-NI Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Proceeds From Life Insurance Policies us-gaap/2025 0 0 monetary D D Proceeds from Life Insurance Policy Amount of cash inflow for proceeds from settlement of corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy.
Proceeds From Repayments Of Secured Debt us-gaap/2025 0 0 monetary D D Proceeds from (Repayments of) Secured Debt Amount of cash inflow (outflow) from long-term debt wholly or partially secured by collateral. Excludes tax exempt secured debt.
Proceeds From Sale And Maturity Of Available For Sale Securities us-gaap/2025 0 0 monetary D D Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Repayments Of Senior Debt us-gaap/2025 0 0 monetary D C Repayments of Senior Debt The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.
Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2025 0 0 monetary D D Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Deferred Policy Acquisition Costs us-gaap/2025 0 0 monetary I D Deferred Policy Acquisition Cost Amount of deferred policy acquisition cost capitalized on contract remaining in force.
Dividends us-gaap/2025 0 0 monetary D D Dividends Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.
Equity Securities Fv Ni Cost us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI, Cost Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.
Investments us-gaap/2025 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Life Insurance Corporate Or Bank Owned Amount us-gaap/2025 0 0 monetary I D Life Insurance, Corporate or Bank Owned, Amount This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax us-gaap/2025 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Shares Issued us-gaap/2025 0 0 shares I Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
Unearned Premiums us-gaap/2025 0 0 monetary I C Unearned Premiums Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Equity Method Investments us-gaap/2025 0 0 monetary I D Equity Method Investments This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
Equity Securities Fv Ni us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI, Current Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.
Goodwill us-gaap/2025 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Payments To Acquire Mortgage Notes Receivable us-gaap/2025 0 0 monetary D C Payments to Acquire Mortgage Notes Receivable The cash outflow from the purchase of receivables arising from the mortgage note on real estate.
Premiums Receivable Allowance For Doubtful Accounts us-gaap/2025 0 0 monetary I C Premium Receivable, Allowance for Credit Loss The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Noncontrolling Interest Other Changes 0000860748-25-000131 1 0 monetary D C Noncontrolling Interest, Other Changes Noncontrolling Interest, Other Changes
Revenues us-gaap/2025 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Cash us-gaap/2025 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Income Loss From Equity Method Investments us-gaap/2025 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Income Tax Receivable us-gaap/2025 0 0 monetary I D Income Taxes Receivable Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.
Increase Decrease In Premiums Receivable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Premiums Receivable The change in the premium receivable balance on the balance sheet.
Increase Decrease In Reinsurance Recoverable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Reinsurance Recoverable The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.
Interest Paid Net us-gaap/2025 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activity Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax us-gaap/2025 0 0 monetary D D Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.
Other Short Term Investments us-gaap/2025 0 0 monetary I D Other Short-Term Investments Amount of short-term investments classified as other.
Payments For Proceeds From Short Term Investments us-gaap/2025 0 0 monetary D C Payments for (Proceeds from) Short-Term Investments The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Payments To Acquire Productive Assets us-gaap/2025 0 0 monetary D C Payments to Acquire Productive Assets The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
Share Based Awards Net Of Shares Exchanged 0000860748-25-000131 1 0 monetary D C Share Based Awards Net Of Shares Exchanged Value of Shares issued during the period as a result of the exercise of stock options and vesting of restricted net of the value of shares withheld or surrendered to satisfy the exercise price and tax withholding obligations
Accrued Liabilities And Other Liabilities us-gaap/2025 0 0 monetary I C Accrued Liabilities and Other Liabilities Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.
Additional Paid In Capital Common Stock us-gaap/2025 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.
Borrowings Under Guaranteed Investment Agreements us-gaap/2025 0 0 monetary I C Borrowings under Guaranteed Investment Agreements Carrying value as of the balance sheet date of the sum of the obligations to contract holders to provide to them an agreed upon rate of return pursuant to the terms of the underlying contract. These contracts represent lending by the contract holders to the entity in return for a guaranteed (primarily fixed) interest rate until maturity, unless called earlier if the contracts provide that option to the contract holders (usually institutions). There is little or no insurance risk for the entity.
Capital Lease Obligations Incurred us-gaap/2025 0 0 monetary D C Lease Obligation Incurred Amount of increase in lease obligation from new lease.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Depreciation Amortization And Accretion Net us-gaap/2025 0 0 monetary D D Depreciation, Amortization and Accretion, Net The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.
Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2025 0 0 monetary D C Increase (Decrease) in Deferred Policy Acquisition Costs The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers.
Liability For Claims And Claims Adjustment Expense us-gaap/2025 0 0 monetary I C Liability for Claims and Claims Adjustment Expense The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
Liability For Future Policy Benefits Period Expense us-gaap/2025 0 0 monetary D D Liability for Future Policy Benefits, Period Expense (Income) Amount of expense (income) recognized due to changes in the accrued obligation to policyholders that relates to insured events.
Proceeds From Payments For Other Financing Activities us-gaap/2025 0 0 monetary D D Proceeds from (Payment for) Other Financing Activity Amount of cash inflow (outflow) from financing activity, classified as other.
Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2025 0 0 monetary D D Proceeds from Sale of Equity Securities, FV-NI Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Income Taxes Paid Net us-gaap/2025 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Available For Sale Debt Securities Amortized Cost Basis us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale, Amortized Cost Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital us-gaap/2025 0 0 monetary D D Proceeds from Equity Method Investment, Distribution, Return of Capital Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.
Stock Issued During Period Shares Employee Stock Ownership Plan us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, Employee Stock Ownership Plan Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.
Stock Repurchased And Retired During Period Shares us-gaap/2025 0 0 shares D Stock Repurchased and Retired During Period, Shares Number of shares that have been repurchased and retired during the period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000860748-25-000131 2 1 IS 0 H Premiums Earned Net us-gaap/2025 Earned Premiums 0
0000860748-25-000131 2 2 IS 0 H Net Investment Income us-gaap/2025 Net Investment Income 0
0000860748-25-000131 2 3 IS 0 H Other Income us-gaap/2025 Other Income 0
0000860748-25-000131 2 4 IS 0 H Equity Securities Fv Ni Gain Loss us-gaap/2025 Change in Fair Value of Equity and Convertible Securities 0
0000860748-25-000131 2 5 IS 0 H Realized Investment Gains Losses us-gaap/2025 Net Realized Investment Gains 0
0000860748-25-000131 2 6 IS 0 H Gain Loss On Asset Impairment Charges 0000860748-25-000131 Impairment Losses 0
0000860748-25-000131 2 7 IS 0 H Revenues us-gaap/2025 Total Revenues 0
0000860748-25-000131 2 9 IS 0 H Liability For Future Policy Benefits Period Expense us-gaap/2025 Remeasurement loss 0
0000860748-25-000131 2 10 IS 0 H Other Cost And Expense Operating us-gaap/2025 Insurance and Other Expenses 0
0000860748-25-000131 2 11 IS 0 H Interest And Other Expenses 0000860748-25-000131 Interest Expense 0
0000860748-25-000131 2 12 IS 0 H Benefits Losses And Expenses us-gaap/2025 Total Expenses 0
0000860748-25-000131 2 13 IS 0 H Income Loss Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Income before Income Taxes 0
0000860748-25-000131 2 14 IS 0 H Income Tax Expense Benefit us-gaap/2025 Income Tax Expense 1
0000860748-25-000131 2 15 IS 0 H Profit Loss us-gaap/2025 Net Income 0
0000860748-25-000131 2 16 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 Less: Net Loss attributable to Noncontrolling Interest 0
0000860748-25-000131 2 17 IS 0 H Net Income Loss us-gaap/2025 Net Income attributable to Kemper Corporation 0
0000860748-25-000131 2 19 IS 0 H Earnings Per Share Basic us-gaap/2025 Basic (in dollars per share) 0
0000860748-25-000131 2 20 IS 0 H Earnings Per Share Diluted us-gaap/2025 Diluted (in dollars per share) 0
0000860748-25-000131 3 7 CI 0 H Profit Loss us-gaap/2025 Net Income 0
0000860748-25-000131 3 9 CI 0 H Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax us-gaap/2025 Changes in Unrealized Gains (Losses) on Investment Securities with: 0
0000860748-25-000131 3 10 CI 0 H Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax us-gaap/2025 Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 1
0000860748-25-000131 3 11 CI 0 H Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax us-gaap/2025 Gain on Cash Flow Hedges 0
0000860748-25-000131 3 12 CI 0 H Change In Discount Rate On Future Life Policyholder Benefits 0000860748-25-000131 Change in Discount Rate on Future Life Policyholder Benefits 0
0000860748-25-000131 3 13 CI 0 H Other Comprehensive Income Loss Before Tax us-gaap/2025 Other Comprehensive Income (Loss), before Tax, Total 0
0000860748-25-000131 3 14 CI 0 H Other Comprehensive Income Loss Tax us-gaap/2025 Other Comprehensive Income Tax Expense 0
0000860748-25-000131 3 15 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other Comprehensive Income, Net of Taxes 0
0000860748-25-000131 3 16 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Total Comprehensive Income 0
0000860748-25-000131 3 17 CI 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2025 Less: Net Loss attributable to Noncontrolling Interest 0
0000860748-25-000131 3 18 CI 0 H Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest us-gaap/2025 Less: Other Comprehensive Income attributable to Noncontrolling Interest 0
0000860748-25-000131 3 19 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2025 Less: Total Comprehensive Loss attributable to Noncontrolling Interest 0
0000860748-25-000131 3 20 CI 0 H Comprehensive Income Net Of Tax us-gaap/2025 Total Comprehensive Income 0
0000860748-25-000131 4 13 BS 0 H Available For Sale Securities Debt Securities us-gaap/2025 Fixed Maturities at Fair Value 0
0000860748-25-000131 4 14 BS 0 H Equity Securities Fv Ni us-gaap/2025 Equity Securities at Fair Value 0
0000860748-25-000131 4 15 BS 0 H Equity Method Investments us-gaap/2025 Alternative Energy Partnership Investments 0
0000860748-25-000131 4 16 BS 0 H Other Short Term Investments us-gaap/2025 Short-term Investments at Cost which Approximates Fair Value 0
0000860748-25-000131 4 17 BS 0 H Life Insurance Corporate Or Bank Owned Amount us-gaap/2025 Company-Owned Life Insurance 0
0000860748-25-000131 4 18 BS 0 H Loans Insurance Policy us-gaap/2025 Loans to Policyholders 0
0000860748-25-000131 4 19 BS 0 H Other Investments us-gaap/2025 Other Investments 0
0000860748-25-000131 4 20 BS 0 H Investments us-gaap/2025 Total Investments 0
0000860748-25-000131 4 21 BS 0 H Cash us-gaap/2025 Cash 0
0000860748-25-000131 4 22 BS 0 H Premiums Receivable At Carrying Value us-gaap/2025 Receivables from Policyholders 0
0000860748-25-000131 4 23 BS 0 H Other Receivables us-gaap/2025 Other Receivables 0
0000860748-25-000131 4 24 BS 0 H Deferred Policy Acquisition Costs us-gaap/2025 Deferred Policy Acquisition Costs 0
0000860748-25-000131 4 25 BS 0 H Goodwill us-gaap/2025 Goodwill 0
0000860748-25-000131 4 26 BS 0 H Income Tax Receivable us-gaap/2025 Current Income Tax Assets 0
0000860748-25-000131 4 27 BS 0 H Deferred Income Tax Assets Net us-gaap/2025 Deferred Income Tax Assets 0
0000860748-25-000131 4 28 BS 0 H Other Assets us-gaap/2025 Other Assets 0
0000860748-25-000131 4 29 BS 0 H Assets us-gaap/2025 Total Assets 0
0000860748-25-000131 4 32 BS 0 H Liability For Claims And Claims Adjustment Expense us-gaap/2025 Insurance Reserves 0
0000860748-25-000131 4 33 BS 0 H Unearned Premiums us-gaap/2025 Unearned Premiums 0
0000860748-25-000131 4 34 BS 0 H Borrowings Under Guaranteed Investment Agreements us-gaap/2025 Policyholder Obligations 0
0000860748-25-000131 4 35 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2025 Deferred Income Tax Liabilities 0
0000860748-25-000131 4 36 BS 0 H Accrued Liabilities And Other Liabilities us-gaap/2025 Accrued Expenses and Other Liabilities 0
0000860748-25-000131 4 37 BS 0 H Long Term Debt Current us-gaap/2025 Long-term Debt, Current, at Amortized Cost 0
0000860748-25-000131 4 38 BS 0 H Long Term Debt Noncurrent us-gaap/2025 Long-term Debt, Non-Current, at Amortized Cost 0
0000860748-25-000131 4 39 BS 0 H Liabilities us-gaap/2025 Total Liabilities 0
0000860748-25-000131 4 41 BS 0 H Common Stock Value Outstanding us-gaap/2025 Common Stock, $0.10 Par Value, 100,000,000 Shares Authorized; 63,978,865 Shares Issued and Outstanding at March 31, 2025 and 63,840,442 Shares Issued and Outstanding at December 31, 2024 0
0000860748-25-000131 4 42 BS 0 H Additional Paid In Capital Common Stock us-gaap/2025 Paid-in Capital 0
0000860748-25-000131 4 43 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Retained Earnings 0
0000860748-25-000131 4 44 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Accumulated Other Comprehensive Loss 0
0000860748-25-000131 4 45 BS 0 H Stockholders Equity us-gaap/2025 Total Kemper Corporation Shareholders Equity 0
0000860748-25-000131 4 46 BS 0 H Minority Interest us-gaap/2025 Noncontrolling Interest 0
0000860748-25-000131 4 47 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Total Shareholders Equity 0
0000860748-25-000131 4 48 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total Liabilities and Shareholders Equity 0
0000860748-25-000131 5 7 BS 1 H Available For Sale Debt Securities Amortized Cost Basis us-gaap/2025 Fixed maturities, at amortized cost 0
0000860748-25-000131 5 8 BS 1 H Debt Securities Available For Sale Allowance For Credit Loss us-gaap/2025 Fixed maturities, allowance for credit losses 0
0000860748-25-000131 5 9 BS 1 H Equity Securities Fv Ni Cost us-gaap/2025 Equity securities, at cost 0
0000860748-25-000131 5 10 BS 1 H Premiums Receivable Allowance For Doubtful Accounts us-gaap/2025 Receivables from policyholders, allowance for credit losses 0
0000860748-25-000131 5 11 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in dollars per share) 0
0000860748-25-000131 5 12 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares authorized (in shares) 0
0000860748-25-000131 5 13 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued (in shares) 0
0000860748-25-000131 5 14 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares outstanding (in shares) 0
0000860748-25-000131 6 1 CF 0 H Profit Loss us-gaap/2025 Net Income 0
0000860748-25-000131 6 4 CF 0 H Debt And Equity Securities Realized Gain Loss us-gaap/2025 Net Realized Investment Gains 1
0000860748-25-000131 6 5 CF 0 H Gain Loss On Asset Impairment Charges 0000860748-25-000131 Impairment Losses 1
0000860748-25-000131 6 6 CF 0 H Depreciation Amortization And Accretion Net us-gaap/2025 Depreciation and Amortization of Property, Equipment, Software and Intangible Assets Acquired 0
0000860748-25-000131 6 7 CF 0 H Income Loss From Equity Method Investments us-gaap/2025 Income on Investments in Alternative Energy Partnership 0
0000860748-25-000131 6 8 CF 0 H Equity Securities Fv Ni Gain Loss us-gaap/2025 Change in Fair Value of Equity and Convertible Securities 1
0000860748-25-000131 6 9 CF 0 H Increase Decrease In Premiums Receivable us-gaap/2025 Receivables from Policyholders 1
0000860748-25-000131 6 10 CF 0 H Increase Decrease In Reinsurance Recoverable us-gaap/2025 Reinsurance Recoverables 1
0000860748-25-000131 6 11 CF 0 H Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2025 Deferred Policy Acquisition Costs 1
0000860748-25-000131 6 12 CF 0 H Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve us-gaap/2025 Insurance Reserves 0
0000860748-25-000131 6 13 CF 0 H Increase Decrease In Unearned Premiums us-gaap/2025 Unearned Premiums 0
0000860748-25-000131 6 14 CF 0 H Increase Decrease In Income Taxes us-gaap/2025 Income Taxes 0
0000860748-25-000131 6 15 CF 0 H Increase Decrease In Other Operating Capital Net us-gaap/2025 Other 1
0000860748-25-000131 6 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net Cash Provided by Operating Activities 0
0000860748-25-000131 6 18 CF 0 H Proceeds From Sale And Maturity Of Available For Sale Securities us-gaap/2025 Proceeds from the Sales, Calls and Maturities of Fixed Maturities 0
0000860748-25-000131 6 20 CF 0 H Proceeds From Sale Of Equity Securities Fv Ni us-gaap/2025 Equity Securities 0
0000860748-25-000131 6 21 CF 0 H Proceeds From Sale And Collection Of Mortgage Notes Receivable us-gaap/2025 Mortgage Loans 0
0000860748-25-000131 6 22 CF 0 H Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital us-gaap/2025 Other Investments 0
0000860748-25-000131 6 24 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2025 Fixed Maturities 1
0000860748-25-000131 6 25 CF 0 H Payments To Acquire Equity Securities Fv Ni us-gaap/2025 Equity Securities 1
0000860748-25-000131 6 26 CF 0 H Payments To Acquire Real Estate Held For Investment us-gaap/2025 Real Estate Investments 1
0000860748-25-000131 6 27 CF 0 H Payments To Acquire Mortgage Notes Receivable us-gaap/2025 Mortgage Loans 1
0000860748-25-000131 6 28 CF 0 H Payments To Acquire Interest In Subsidiaries And Affiliates us-gaap/2025 Other Investments 0
0000860748-25-000131 6 29 CF 0 H Payments For Proceeds From Short Term Investments us-gaap/2025 Net Sales of Short-term Investments 1
0000860748-25-000131 6 30 CF 0 H Payments To Acquire Productive Assets us-gaap/2025 Acquisition of Software and Long-lived Assets 1
0000860748-25-000131 6 31 CF 0 H Proceeds From Life Insurance Policies us-gaap/2025 Settlement Proceeds from Company-Owned Life Insurance 0
0000860748-25-000131 6 32 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2025 Other 1
0000860748-25-000131 6 33 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net Cash Provided by Investing Activities 0
0000860748-25-000131 6 35 CF 0 H Repayments Of Senior Debt us-gaap/2025 Repayment of Long-term Debt 1
0000860748-25-000131 6 36 CF 0 H Proceeds From Repayments Of Secured Debt us-gaap/2025 Proceeds from Policyholder Contract Obligations 0
0000860748-25-000131 6 37 CF 0 H Repayments Of Secured Debt us-gaap/2025 Repayment of Policyholder Contract Obligations 1
0000860748-25-000131 6 38 CF 0 H Proceeds From Stock Plans us-gaap/2025 Proceeds from Shares Issued under Employee Stock Purchase Plan 0
0000860748-25-000131 6 39 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2025 Common Stock Repurchases 1
0000860748-25-000131 6 40 CF 0 H Payments Of Dividends us-gaap/2025 Dividends Paid 1
0000860748-25-000131 6 41 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2025 Other 0
0000860748-25-000131 6 42 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net Cash Used in Financing Activities 0
0000860748-25-000131 6 43 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 Net increase (decrease) in cash 0
0000860748-25-000131 6 44 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash, Beginning of Year 0
0000860748-25-000131 6 45 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash, End of Period 0
0000860748-25-000131 6 48 CF 0 H Interest Paid Net us-gaap/2025 Interest 1
0000860748-25-000131 6 49 CF 0 H Income Taxes Paid Net us-gaap/2025 Taxes 0
0000860748-25-000131 6 50 CF 0 H Capital Lease Obligations Incurred us-gaap/2025 Operating Leases 1
0000860748-25-000131 6 52 CF 0 H Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2025 Right-of-Use Assets Obtained in Exchange for New Operating Lease Liabilities 0
0000860748-25-000131 7 11 EQ 0 H Shares Issued us-gaap/2025 Beginning balance (in shares) 0
0000860748-25-000131 7 12 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Beginning balance 0
0000860748-25-000131 7 13 EQ 0 H Profit Loss us-gaap/2025 Net Income 0
0000860748-25-000131 7 14 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other Comprehensive Income, Net of Tax 0
0000860748-25-000131 7 15 EQ 0 H Dividends us-gaap/2025 Cash Dividends and Dividend Equivalents to Shareholders 1
0000860748-25-000131 7 16 EQ 0 H Stock Repurchased And Retired During Period Shares us-gaap/2025 Stock repurchased and retired during period (in shares) 0
0000860748-25-000131 7 17 EQ 0 H Stock Repurchased And Retired During Period Value us-gaap/2025 Repurchases of Common Stock (Note 13) 1
0000860748-25-000131 7 18 EQ 0 H Stock Issued During Period Shares Employee Stock Ownership Plan us-gaap/2025 Shares Issued Under Employee Stock Purchase Plan (in shares) 0
0000860748-25-000131 7 19 EQ 0 H Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2025 Shares Issued Under Employee Stock Purchase Plan 0
0000860748-25-000131 7 20 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 Equity-based Compensation Cost 0
0000860748-25-000131 7 21 EQ 0 H Share Based Awards Issued During Period Net Of Shares Exchanged 0000860748-25-000131 Equity-based Awards, Net of Shares Exchanged (in shares) 0
0000860748-25-000131 7 22 EQ 0 H Share Based Awards Net Of Shares Exchanged 0000860748-25-000131 Share Based Awards Net Of Shares Exchanged 0
0000860748-25-000131 7 23 EQ 0 H Noncontrolling Interest Other Changes 0000860748-25-000131 Other Changes in Non-Controlling Interest 0
0000860748-25-000131 7 24 EQ 0 H Shares Issued us-gaap/2025 Ending balance (in shares) 0
0000860748-25-000131 7 25 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2025 Ending balance 0
0000860748-25-000131 8 1 EQ 1 H Common Stock Dividends Per Share Cash Paid us-gaap/2025 Dividends paid to shareholders per share (in dollars per share) 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.